Genetic Polymorphisms and Haplotypes of POR, Encoding Cytochrome P450 Oxidoreductase, in a Japanese Population

被引:20
作者
Saito, Yoshiro [1 ,2 ]
Yamamoto, Noboru [3 ]
Katori, Noriko [2 ,4 ]
Maekawa, Keiko [2 ]
Fukushima-Uesaka, Hiromi [2 ]
Sugimoto, Daisuke [5 ]
Kurose, Kouichi [2 ]
Sai, Kimie [2 ,5 ]
Kaniwa, Nahoko [2 ]
Sawada, Jun-ichi [2 ,6 ]
Kunitoh, Hideo [3 ]
Ohe, Yuichiro [3 ]
Yoshida, Teruhiko [7 ]
Matsumura, Yasuhiro [8 ]
Saijo, Nagahiro [9 ]
Okuda, Haruhiro [2 ,6 ]
Tamura, Tomohide [3 ]
机构
[1] Natl Inst Hlth Sci, Div Med Safety Sci, Setagaya Ku, Tokyo 1588501, Japan
[2] Natl Inst Hlth Sci, Project Team Pharmacogenet, Tokyo 1588501, Japan
[3] Natl Canc Ctr, Thorac Oncol Div, Tokyo, Japan
[4] Natl Inst Hlth Sci, Div Drugs, Tokyo, Japan
[5] Natl Inst Hlth Sci, Div Funct Biochem & Genom, Tokyo, Japan
[6] Natl Inst Hlth Sci, Div Organ Chem, Tokyo, Japan
[7] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 104, Japan
[8] Res Ctr Innovat Oncol, Invest Treatment Div, Kashiwa, Chiba, Japan
[9] Natl Canc Ctr Hosp E, Kashiwa, Chiba, Japan
基金
日本学术振兴会;
关键词
POR; genetic polymorphism; haplotype; Japanese; nonsynonymous variation; ANTLEY-BIXLER-SYNDROME; P450; OXIDOREDUCTASE; STEROIDOGENESIS; MUTATIONS;
D O I
10.2133/dmpk.DMPK-10-SC-096
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cytochrome P450 oxidoreductase (POR) transfers electrons from NADPH to all microsomal cytochrome P450 (CYP) enzymes and is necessary for microsomal CYP activities. In this study, to find genetic variations and to elucidate the haplotype structures of POR, we comprehensively screened the genetic variations in the 5'-flanking region, all the exons and their flanking introns of POR for 235 Japanese subjects. Seventy-five genetic variations including 26 novel ones were found: 7 were in the 5'-flanking region, 2 in the 5'-untranslated region (5'-UTR, non-coding exon 1), 16 in the coding exons (10 nonsynonymous and 6 synonymous), 45 in the introns, 4 in the 3'-UTR and 1 in the 3'-flanking region. Of these, 4 novel nonsynonymous variations, 86C > T (T29M), 1648C > T (R550W), 1708C > T (R570C) and 1975G > A (A659T), were detected with allele frequencies of 0.002. We also detected known non-synonymous SNPs 683C > T (P228L), 1237G > A (G413S), 1453G > A (A485T), 1508C > T (A503V), 1510G > A (G504R) and 1738G > C (E580Q) with frequencies of 0.002, 0.009, 0.002, 0.434, 0.002 and 0.002, respectively. Based on the linkage disequilibrium (LD) profiles, the analyzed region could be divided into two LD blocks. For Blocks 1 and 2, 14 and 46 haplotypes were inferred, respectively, and 2 and 6 common haplotypes found in more than 0.03 frequencies accounted for more than 81% of the inferred haplotypes. This study provides fundamental and useful information for the pharmacogenetic studies of drugs metabolized by CYPs in the Japanese population.
引用
收藏
页码:107 / 116
页数:10
相关论文
共 11 条
[1]   Pharmacogenetics of P450 oxidoreductase: effect of sequence variants on activities of CYP1A2 and CYP2C19 [J].
Agrawal, Vishal ;
Huang, Ningwu ;
Miller, Walter L. .
PHARMACOGENETICS AND GENOMICS, 2008, 18 (07) :569-576
[2]   Cytochrome P450 oxidoreductase gene mutations and Antley-Bixler syndrome with abnormal genitalia and/or impaired steroidogenesis: Molecular and clinical studies in 10 patients [J].
Fukami, M ;
Horikawa, R ;
Nagai, T ;
Tanaka, T ;
Naiki, Y ;
Sato, N ;
Okuyama, T ;
Nakai, H ;
Soneda, S ;
Tachibana, K ;
Matsuo, N ;
Sato, S ;
Homma, K ;
Nishimura, G ;
Hasegawa, T ;
Ogata, T .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (01) :414-426
[3]   Pharmacogenomics of human liver cytochrome P450 oxidoreductase: multifactorial analysis and impact on microsomal drug oxidation [J].
Gomes, Ana M. ;
Winter, Stefan ;
Klein, Kathrin ;
Turpeinen, Miia ;
Schaeffeler, Elke ;
Schwab, Matthias ;
Zanger, Ulrich M. .
PHARMACOGENOMICS, 2009, 10 (04) :579-599
[4]  
Hart SN, 2008, EXPERT OPIN DRUG MET, V4, P439, DOI [10.1517/17425255.4.4.439, 10.1517/17425255.4.4.439 ]
[5]   Novel SNPs in cytochrome p450 oxidoreductase [J].
Hart, Steven N. ;
Li, Ye ;
Nakamoto, Kaori ;
Wesselman, Chris ;
Zhong, Xiao-Bo .
DRUG METABOLISM AND PHARMACOKINETICS, 2007, 22 (04) :322-326
[6]   Urine steroid hormone profile analysis in cytochrome P450 oxidoreductase deficiency: Implication for the backdoor pathway to dihydrotestosterone [J].
Homma, Keiko ;
Hasegawa, Tomonobu ;
Nagai, Toshiro ;
Adachi, Masanori ;
Horikawa, Reiko ;
Fujiwara, Ikuma ;
Tajima, Toshihiro ;
Takeda, Ryoujun ;
Fukami, Maki ;
Ogata, Tsutomu .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (07) :2643-2649
[7]   Genetics of P450 oxidoreductase: Sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations [J].
Huang, Ningwu ;
Agrawal, Vishal ;
Giacomini, Kathleen M. ;
Miller, Walter L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (05) :1733-1738
[8]   Diversity and function of mutations in p450 oxidoreductase in patients with Antley-Bixler Syndrome and disordered steroidogenesis [J].
Huang, NW ;
Pandey, AV ;
Agrawal, V ;
Reardon, W ;
Lapunzina, PD ;
Mowat, D ;
Jabs, EW ;
Van Vliet, G ;
Sack, J ;
Flück, CE ;
Miller, WL .
AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (05) :729-749
[9]   Minireview: Regulation of steroidogenesis by electron transfer [J].
Miller, WL .
ENDOCRINOLOGY, 2005, 146 (06) :2544-2550
[10]   ISOLATION OF A HUMAN CYTOCHROME-P-450 REDUCTASE CDNA CLONE AND LOCALIZATION OF THE CORRESPONDING GENE TO CHROMOSOME-7Q11.2 [J].
SHEPHARD, EA ;
PHILLIPS, IR ;
SANTISTEBAN, I ;
WEST, LF ;
PALMER, CNA ;
ASHWORTH, A ;
POVEY, S .
ANNALS OF HUMAN GENETICS, 1989, 53 :291-301